1 results match your criteria: "National Hospital Organization (NHO) Hiroshima-Nishi Medical Center[Affiliation]"
Cureus
June 2024
Department of Cardiology, National Hospital Organization (NHO) Hiroshima-Nishi Medical Center, Otake, JPN.
Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease that is genetically transmitted as an autosomal dominant trait. Even apical HCM (ApHCM) induces atrial fibrillation (AF) based on underlying left ventricle (LV) diastolic dysfunction, where anticoagulation therapy is recommended. However, anticoagulation for AF in patients at high risk of bleeding is a double-edged sword.
View Article and Find Full Text PDF